Not Yet Recruiting
RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies
NCT07113496
- Conditions
- B-cell Acute Lymphoblastic Leukemia (B-ALL), Blood Protein Disorders, Burkitt Lymphoma, +34 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China